News • Targeted immunotherapy
Implantable cytokine factories to help treat ovarian cancer
Researchers have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.





































